These results demonstrate novel downstream mechanisms of STAT3 and reveal that NP, which effectively blocks osteosarcoma growth in vitro and in vivo, could be further explored clinically in the control of osteosarcoma tumors and metastasis. Here, STAT3 is linked to osteosarcoma.